Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Until just a few decades ago, raised blood pressure was regarded as a benign and natural process of ageing that did not warrant treatment.

Professor Kazem Rahimi, Director of the George Institute comments in the Lancet that effective control of raised blood pressure requires collaborative, multi-sectoral, national efforts to improve implementation of available evidence. The failure to tackle this issue more decisively will come at a high cost, particularly to disadvantaged individuals and societies.

The clear view of recent achievements, as provided by the NCD Risk Factor Collaboration, should help us to collectively steer the action plan more effectively and equitably towards decreasing blood pressure globally.



Published Online November 15 2016


Our Research Groups